Cargando…

Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study

OBJECTIVES: To estimate the number needed to screen (NNS) and the number needed to treat (NNT) to prevent one tuberculosis (TB) case in the Norwegian immigrant latent tuberculosis infection (LTBI) screening programme and to explore the effect of delay of LTBI treatment initiation. DESIGN: Population...

Descripción completa

Detalles Bibliográficos
Autores principales: Winje, Brita Askeland, Grøneng, Gry Marysol, White, Richard Aubrey, Akre, Peter, Aavitsland, Preben, Heldal, Einar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340421/
https://www.ncbi.nlm.nih.gov/pubmed/30782706
http://dx.doi.org/10.1136/bmjopen-2018-023412
_version_ 1783388792278745088
author Winje, Brita Askeland
Grøneng, Gry Marysol
White, Richard Aubrey
Akre, Peter
Aavitsland, Preben
Heldal, Einar
author_facet Winje, Brita Askeland
Grøneng, Gry Marysol
White, Richard Aubrey
Akre, Peter
Aavitsland, Preben
Heldal, Einar
author_sort Winje, Brita Askeland
collection PubMed
description OBJECTIVES: To estimate the number needed to screen (NNS) and the number needed to treat (NNT) to prevent one tuberculosis (TB) case in the Norwegian immigrant latent tuberculosis infection (LTBI) screening programme and to explore the effect of delay of LTBI treatment initiation. DESIGN: Population-based, prospective cohort study. PARTICIPANTS: Immigrants to Norway. OUTCOME: Incident TB. METHODS: We obtained aggregated data on immigration to Norway in 2008–2011 and used data from the Norwegian Surveillance System for Infectious Diseases to assess the number of TB cases arising in this cohort within 5 years after arrival. We calculated the average NNS and NNT for immigrants from the top 10 source countries for TB in Norway and by estimated TB incidence rates in source countries. We explored the sensitivity of these estimates with regard to test performance, treatment efficacy and treatment adherence using an extreme value approach, and assessed the effects of emigration, time to TB diagnosis (to define incident TB) and intervention timing. RESULTS: NNS and NNT were overall high, with substantial variation. NNT showed numerically stronger negative correlation with TB notification rate in Norway (−0.75 [95% CI −1.00 to −0.44]) than with the WHO incidence rate (IR) (−0.32 [95% CI −0.93 to 0.29]). NNT was affected substantially by emigration and the definition of incident TB. Estimates were lowest for Somali (NNS 99 [70–150], NNT 27 [19–41]) and highest for Thai immigrants (NNS 585 [413–887], NNT 111 [79–116]). Implementing LTBI treatment in immigrants sooner after arrival may improve the effectiveness of the programme. CONCLUSION: Using TB notifications in Norway, rather than IR in source countries, would improve targeting of immigrants for LTBI management. However, the overall high NNT is a concern and challenges the scale-up of preventive LTBI treatment for significant public health impact. Better data are urgently needed to monitor and evaluate NNS and NNT in countries implementing LTBI screening.
format Online
Article
Text
id pubmed-6340421
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-63404212019-02-02 Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study Winje, Brita Askeland Grøneng, Gry Marysol White, Richard Aubrey Akre, Peter Aavitsland, Preben Heldal, Einar BMJ Open Infectious Diseases OBJECTIVES: To estimate the number needed to screen (NNS) and the number needed to treat (NNT) to prevent one tuberculosis (TB) case in the Norwegian immigrant latent tuberculosis infection (LTBI) screening programme and to explore the effect of delay of LTBI treatment initiation. DESIGN: Population-based, prospective cohort study. PARTICIPANTS: Immigrants to Norway. OUTCOME: Incident TB. METHODS: We obtained aggregated data on immigration to Norway in 2008–2011 and used data from the Norwegian Surveillance System for Infectious Diseases to assess the number of TB cases arising in this cohort within 5 years after arrival. We calculated the average NNS and NNT for immigrants from the top 10 source countries for TB in Norway and by estimated TB incidence rates in source countries. We explored the sensitivity of these estimates with regard to test performance, treatment efficacy and treatment adherence using an extreme value approach, and assessed the effects of emigration, time to TB diagnosis (to define incident TB) and intervention timing. RESULTS: NNS and NNT were overall high, with substantial variation. NNT showed numerically stronger negative correlation with TB notification rate in Norway (−0.75 [95% CI −1.00 to −0.44]) than with the WHO incidence rate (IR) (−0.32 [95% CI −0.93 to 0.29]). NNT was affected substantially by emigration and the definition of incident TB. Estimates were lowest for Somali (NNS 99 [70–150], NNT 27 [19–41]) and highest for Thai immigrants (NNS 585 [413–887], NNT 111 [79–116]). Implementing LTBI treatment in immigrants sooner after arrival may improve the effectiveness of the programme. CONCLUSION: Using TB notifications in Norway, rather than IR in source countries, would improve targeting of immigrants for LTBI management. However, the overall high NNT is a concern and challenges the scale-up of preventive LTBI treatment for significant public health impact. Better data are urgently needed to monitor and evaluate NNS and NNT in countries implementing LTBI screening. BMJ Publishing Group 2019-01-17 /pmc/articles/PMC6340421/ /pubmed/30782706 http://dx.doi.org/10.1136/bmjopen-2018-023412 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Infectious Diseases
Winje, Brita Askeland
Grøneng, Gry Marysol
White, Richard Aubrey
Akre, Peter
Aavitsland, Preben
Heldal, Einar
Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
title Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
title_full Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
title_fullStr Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
title_full_unstemmed Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
title_short Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
title_sort immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a norwegian population-based cohort study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340421/
https://www.ncbi.nlm.nih.gov/pubmed/30782706
http://dx.doi.org/10.1136/bmjopen-2018-023412
work_keys_str_mv AT winjebritaaskeland immigrantscreeningforlatenttuberculosisinfectionnumbersneededtotestandtreatanorwegianpopulationbasedcohortstudy
AT grønenggrymarysol immigrantscreeningforlatenttuberculosisinfectionnumbersneededtotestandtreatanorwegianpopulationbasedcohortstudy
AT whiterichardaubrey immigrantscreeningforlatenttuberculosisinfectionnumbersneededtotestandtreatanorwegianpopulationbasedcohortstudy
AT akrepeter immigrantscreeningforlatenttuberculosisinfectionnumbersneededtotestandtreatanorwegianpopulationbasedcohortstudy
AT aavitslandpreben immigrantscreeningforlatenttuberculosisinfectionnumbersneededtotestandtreatanorwegianpopulationbasedcohortstudy
AT heldaleinar immigrantscreeningforlatenttuberculosisinfectionnumbersneededtotestandtreatanorwegianpopulationbasedcohortstudy